Boston Scientific Corporation (BSX)
Makes medical devices that diagnose and treat heart, digestive, and nerve problems
$46.40+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-56.0%
The outlook
Boston Scientific trades near its 52-week low and sits below both its 50- and 200-day moving averages, suggesting weakness in recent momentum. Analysts overwhelmingly favor the stock with a Strong Buy consensus, and their average price target sits about 56% above the current price. The overall picture is mixed—solid analyst conviction paired with a stock trading at depressed technical levels.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 28 analysts
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +56% vs current price
Analyst price target
~12-month · 28 analysts$72.43average target+56.1% vs now
Now $46.40
Low $55.00High $106.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$68.97B
52-wk high
$109.50
52-wk low
$42.20
50-day avg
$47.29
200-day avg
$74.17
Trailing P/E
19.4